Meet the weight-management clinical criteria (measured at the time GLP-1 therapy was first started): BMI of 35 or higher, or BMI of 30 or higher with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or chronic kidney disease (stage 3a or above), or BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease
The psychological benefitsconfidence in food choices, reduced obsession with eating, and restored sense of controloften match or exceed the physical weight loss in patient satisfaction reports
While the magnitude of this effect varies among individuals, even modest increases in metabolic rate can support sustained fat loss over time
Staying on semaglutide for longer periods allows your brain and metabolism to adapt more deeply to lower calorie intake and increased satiety
They may recommend stopping lipotropics or switching the ingredients you are using